Review article: Olestra and its gastrointestinal safety

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 12, 1998, Pages 1185-1200

  Thomson, A B R ^a   Hunt, R H ^b   Zorich, N L ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c PROCTER AND GAMBLE COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BILE ACID; CHOLESTEROL; DIAZEPAM; ETHINYLESTRADIOL; NORETHISTERONE; NORGESTREL; PANCREAS ENZYME; PROPRANOLOL; RETINOL; SUCROSE POLYESTER; VITAMIN D; VITAMIN K GROUP;

ABDOMINAL CRAMP; ALPHA TOCOPHEROL DEFICIENCY; BILE ACID METABOLISM; CALORIC INTAKE; CHOLESTEROL METABOLISM; CLINICAL TRIAL; DIARRHEA; DOSE RESPONSE; DRUG METABOLISM; FAT INTAKE; FAT SUBSTITUTE; FECES; FLATULENCE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT FUNCTION; GASTROINTESTINAL TRANSIT; HUMAN; INTESTINE ABSORPTION; INTESTINE FLORA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINOL DEFICIENCY; REVIEW; STOMACH EMPTYING; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANIMALS; AVITAMINOSIS; BIOLOGICAL AVAILABILITY; DIGESTIVE SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FAT SUBSTITUTES; FATTY ACIDS; FOOD-DRUG INTERACTIONS; HUMANS; SUCROSE;

EID: 0031678461     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00415.x     Document Type: Review

References (94)

1. Kester JJ. Food product development using olestra as a fat substitute. In: Yalpani M, ed. Science for the Food Industry of the 21st Century: Biotechnology, Supercritical Fluids, Membranes and Other Advanced Technologies for Low Calorie. Healthy Food Alternatives. Vol. 1. Frontiers and Food Ingredients. Mount prospect. IL: ATL Press, Inc., 1972: 37-50.
2. Mattson FH, Volpenhein RA. Hydrolysis of fully esterified alcohols containing from one to eight hydroxyl groups by the lipolytic enzymes of rat pancreatic juice. J Lipid Res 1972; 13: 325-8.
3. Mattson FH, Volpenhein RA. Rate and extent of absorption of the fatty acids of fully esterified glycerol, erythritol, xylitol, and sucrose as measured in thoracic duct cannulated rats. J Nutr 1972; 102: 1177-80.
4. Miller KW, Lawson KD, Tallmadge DH, et al. Disposition of ingested olestra in the Fischer 344 rat. Fundam Appl Toxicol 1995; 24: 229-37.
5. Daher GC, Lawson KD, Tallmadge DH, Vanderploeg P, Miller KW. Disposition of ingested olestra in weanling mini-pigs. Food Chem Toxicol 1996; 34: 693-9.
6. Daher GC, Lawson KD, Long PH, et al. Comparison of olestra absorption in guinea pigs with normal and compromised gastrointestinal tracts. Fundam Appl Toxicol 1996; 39: 138-47.
7. Fallat RW, Glueck CJ, Lutmer R, Mattson FH. Short term study of sucrose polyester a nonabsorbable fat-like material as a dietary agent for lowering plasma cholesterol. Am J Clin Nutr 1976; 29: 1204-15.
8. Mattson F, Hollenbach E, Kuehlthau C. The effect of a non-absorbed fat, sucrose polyester, on the metabolism of vitamin A by the rat. J Nutr 1979; 109: 1688-93.
9. Jandacek R. The effect of nonabsorbable lipids on the intestinal absorption of lipophiles. Drug Metab Rev 1982; 13(4): 695-714.
10. Schlagheck T, Kesler J, Jones M, Zorich N, Dugan L, Peters J. Olestra's effect on vitamin D and E in humans can be offset by increasing dietary levels of these vitamins. J Nutr 1997; 127: S1666-85.
11. Schlagheck T, Riccardi K, Zorich N, Torri S, Dugan L, Peters J. Olestra dose response to fat-soluble and water-soluble nutrients in humans. J Nutr 1997; 127: S1547-54.
12. Jandacek R, Ramirez M, Crouse J. Effects of partial replacement of dietary fat by olestra on dietary cholesterol absorption in man. Metabolism 1990; 39(8): 848-52.
13. Wood F, Tierney W, Knezevich A, Bolte H, Maurer J, Bruce R. Chronic toxicity and carcinogenicity studies of olestra in Fischer 344 rats. Food Chem Toxicol 1991; 29(4): 231-6.
14. Lafranconi WM, Long PH, Atkinson JE, Knezevich AL, Wooding WL. Chronic toxicity and carcinogenicity of olestra in Swiss CD-1 mice. Food Chem Toxicol 1994; 32: 789-98.
15. Food and Drug Administration (FDA). Food additives permitted for direct addition to food for human consumption: olestra; final rule. Fed Regist 1996; 61: 3118-73.
16. Henry DE, Tallmadge DH, Sanders RA, Gardner DR. Characterization of used frying oils. Part 2: comparison of olestra and triglyceride. J Am Oil Chem Soc 1992; 69: 509-19.
17. Lawson KD, Middleton SJ, Hassall CD. Olestra, a nonabsorbed. noncaloric replacement for dietary fat: a review. Drug Metab Rev 1997; 29: 651-703.
18. Jandacek RJ, Webb MR. Physical properties of pure sucrose octaesters. Chem Phys Lipids 1978; 22: 163-76.
19. American Dietetic Association. Position of the American Dietetic Association: Fat replacers. J Am Diet Assoc 1998; 98: 463-8.
20. Calorie Control Council. 1996. Calorie Control Commentary 18(1): 1-5.
21. Schwenk NE, Guthrie JF. Trends in marketing and usage of fat-modified foods: implications for dietary status and nutrition promotion. Family Econ Nutr Rev 1997; 10: 16-31.
22. Webb DR, Harrison GG, Lee M-J, Huang M-H. Estimated consumption and eating frequency of olestra from savory snacks using menu census data. J Nutr 1997; 127: S1547-54.
23. Miller KW, Wood FE, Stuard SB, Alden CL. A 20-month olestra feeding study in dogs. Food Chem Toxicol 1991; 29: 427-35.
24. Cortot A, Phillips SF, Malagelada J-R. Parallel gastric emptying of nonhydrolyzable fat and water after a solid-liquid meal in humans. Gastroenterology 1982; 82: 877-81.
25. Cortot A, Phillips SF, Malagelada J-R. Gastric emptying of lipids after ingestion of a solid - liquid meal in humans. Gastroenterology 1981; 80: 922-7.
26. Aggarwal AM, Camilleri M, Phillips SF, et al. Olestra, a non-digestible, nonabsorbable fat. Effects on gastrointestinal and colonic transit. Dig Dis Sci 1993; 38: 1009-14.
27. Kelly SM, Hunter JO. The effect of a non-absorbable fat substitute, sucrose polyester, on gastrointestinal function. Aliment Pharmacol Ther 1996; 10: 715-20.
28. Becker DJ, Sinclair J, Castell DO, Wu WC. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol 1989; 84: 782-6.
29. Just R, Katz L, Verhille M, Schlagheck T, Castell D. A comparison of the effect of olestra and triglyceride on postprandial esophageal acid exposure. Am J Gastroenterol 1993; 88: 1734-7.
30. Maas MIM, Hopman WPM, van der Wijk T, Katan MB, Jansen JBMJ. Sucrose polyester does not inhibit gastric acid secretion or stimulate cholecystokinin release in men. Am J Clin Nutr 1997; 65: 761-5.
31. Peters JC, Lawson KD, Middleton SJ, Triebwasser KC. Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: summary. J Nutr 1997; 127: S1719-28.
32. Cooper DA, Berry DA, Spendel VA, King D, Kiorpes AL, Peters JC. Olestra dose response on fat-soluble and water-soluble nutrients in the pig. J Nutr 1997; 127: S1573-88.
33. Jandacek RJ, Mattson FH, McNeely S, Gallon L, Yunker R, Glueck CJ. Effect of sucrose polyester on fecal steroid excretion by 24 normal men. Am J Clin Nutr 1980; 33: 251-9.
34. Daher GC, Cooper DA, Zorich NL, King D, Riccardi KA, Peters JC. Olestra ingestion and dietary fat absorption in humans. J Nutr 1997; 127: S1694-8.
35. Peters JC, Lawson KD, Middleton SJ, Triebwasser KC. Assessment of the nutritional effects of olestra, a nonabsorbed fat replacement: introduction and overview. J Nutr 1997; 127: S1539-46.
36. Cooper DA, Berry DA, Spendel VA, Jones MB, Kiorpes AL, Peters JC. Nutritional status of pigs fed olestra with and without increased dietary levels of vitamin A and E in longterm studies. J Nutr 1997; 127: S1609-35.
37. Schlagheck TG, Riccardi KA, Zorich NL, Torri SA, Dugan LD, Peters JC. Olestra dose response on fat-soluble and water-soluble nutrients in humans. J Nutr 1997; 127: S1646-65.
38. Cooper DA, Webb DR, Peters JC. Evaluation of the potential for olestra to affect the availability of dietary phytochemicals. J Nutr 1997; 127: S1699-709.
39. Cooper DA, Berry DA, Jones MB, Kiorpes AL, Peters JC. Olestra's effect on the status of vitamins A, D and E in the pig can be offset by increasing dietary levels of these vitamins. J Nutr 1997; 127: S1589-608.
40. Miller KW, Williams DS, Carter SB, Jones MB, Mishell DR Jr. The effect of olestra on systemic levels of oral contraceptives. Clin Pharmacol Ther 1990; 48: 34-40.
41. Roberts RJ, Leff RD. Influence of absorbable and nonabsorbable lipids and lipid-like substances on drug bioavailability. Clin Pharmacol Ther 1989; 45: 299-304.
42. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 1996; 96: 1027-39.
43. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 1992; 18: 1-29.
44. National Research Council, Committee on Diet and Health. Diet and Health: Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press, 1989: 6-7.
45. Department of Health and Human Services. The Surgeon General's report on nutrition and health: summary and recommendations. Washington, DC: DHHS (PHS) Publication No. 88-50211, 1988.
46. Willett WC. Diet and health: what should we eat? Science 1994; 264: 532-7.
47. Jacques PF, Hartz SC, Chylack LT Jr, McGandy RB, Sadowski JA. Nutritional status in persons with and without senile cataract: blood vitamin and mineral levels. Am J Clin Nutr 1988; 48: 152-8.
48. Rock CL, Swendseid ME. Plasma β-carotene response in humans after meals supplemented with dietary pectin. Am J Clin Nutr 1992; 55: 96-9.
49. Dimitrov NV Meyer C, Ullrey DE, et al. Bioavailability of β-carotene in humans. Am J Clin Nutr 1988; 48: 298-304.
50. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in make smokers. N Engl J Med 1994; 330: 1029-35.
51. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-5.
52. Hager MH, Schneeman BO. Pancreatic enzyme and plasma cholesterol response to chronic ingestion of a nonabsorbable lipid in rats. J Nutr 1986; 116: 2372-7.
53. Mattson FH, Jandacek RJ. The effect of a non-absorbable fat on the turnover of plasma cholesterol in the rat. Lipids 1985; 20: 273-7.
54. Glueck CJ, Jandecek RJ, Ravi Subbiah MT, et al. Effect of sucrose polyester on faecal bile acid excretion and composition in normal men. Am J Clin Nutr 1980; 33: 2177-81.
55. Grundy SM, Anastasia JV, Kesaniemi YA, Abrams J. Influence of sucrose polyester on plasma lipoproteins, and cholesterol metabolism in obese patients with and without diabetes mellitus. Am J Clin Nutr 1986; 44: 620-9.
56. Crouse JR, Grundy SM. Effects of sucrose polyester on cholesterol metabolism in man. Metabolism 1979; 28: 994-1000.
57. Nuck BA, Schlagheck TG, Federle TW. Inability of the human faecal microflora to metabolize the nonabsorbable fat substitute, olestra. J Ind Microbiol 1994; 13: 328-34.
58. Eastwood MA, Allgood GS. The effect of olestra on breath gas production and faecal microbial counts. Eur J Clin Nutr 1995; 49: 627-39.
59. Siigur U, Norm KE, Allgood G, Schlagheck T, Midtvedt T. Effect of olestra on faecal water and short-chain fatty acids. Microb Ecol Health Dis 1996; 9; 9-17
60. Siigur U, Norin KE, Allgood G, Schlagcheck T, Midtvedt T. Effect of olestra upon intestinal microecology as reflected by five microflora associated characteristics in man. Microb Ecol Health Dis 1996; 9; 295-303.
61. Midtvedt T, Johansson G, Carlstedt-Duke B, Midtvedt A-C, Norin KE, Gustafsson J-Å. The effect of a shift from a mixed to a lacto-vegetarian diet on some intestinal microflora associated characteristics. Microb Ecol Health Dis 1990; 3: 33-8.
62. Midtvedt T, Carlstedt-Duke B, Hoverstad T, et al. Influence of peroral antibodies upon the biotransformatory activity of the intestinal microflora in healthy subjects. Eur J Clin Invest 1986; 16: 11-17.
63. Leijonmarck C-E, Benno P, Carlstedt-Duke B, et al. The function of the intestinal microflora in patients with ulcerative colitis before and after colectomy. Scand J Gastroenterol 1990; 25: 585-93.
64. Carlstedt-Duke B, Hoverstad T, Lingaas E, et al. Influence of antibodies on intestinal mucin in healthy subjects. Eur J Clin Microbiol 1986; 5: 634-8.
65. Cassidy MM, Satchithanandam S, Calvert RJ, Vahouny GV, Leeds AR. Quantitative and qualitative adaptations in gastrointestinal mucin with dietary fiber feeding. In: Kritchevsky D, Bonfield C, Anderson JW, eds. Dietary Fiber. Chemistry, Physiology, and Health Effects. New York: Plenum Press, 1990: 67-88.
66. Johansson G, Midtvedt T, Gustafsson GA. Effects of a shift from a mixed diet to a lactovegetarian diet on some colon cancer associated characteristics. Int J Biosocial Med Res 1991; 13: 77-111.
67. Midtvedt T. Metabolism of endogenous substances. In: de Clerq E, ed. Frontiers in Microbiology. Dordrecht: Martinus Nijhoff Publishers, 1987: 79-87.
68. Midtvedt A-C, Carlstedt-Duke B, Norin KE, Saxerholt H, Midtvedt T. Development of five metabolic activities associated with the intestinal microflora of healthy infants. J Pediatr Gastroenterol Nutr 1988; 7: 559-67.
69. Midtvedt T, Lingaas E, Carlstedt-Duke B, et al. Intestinal microbial conversion of cholesterol to coprostanol in man. Influence of antibodies. APMIS 1990; 98: 839-44.
70. Wilkins TD, Hackman AS. Two patterns of neutral steroid conversion in the feces of normal North Americans. Cancer Res 1974; 34: 2250-4.
71. Saxerholt H, Carlstedt-Duke B, Hoverstad T, et al. Influence of antibiotics on the faecal excretion of bile pigments in healthy subjects. Scand J Gastroenterol 1986; 21: 991-6.
72. Stenhagen E, Rideal EK. The interaction between porphyrins and lipoid and protein monolayers. Biochem J 1939; 33: 1591-8.
73. Hoverstad T, Fausa O, Bjorneklett A, Bohmer T. Short-chain fatty acids in the normal human feces. Scand J Gastroenterol 1984; 19: 375-81.
74. Siigur U, Tamm A, Tammur R. The faecal SCFAs and lactose tolerance in lactose malabsorbers. Eur J Gastroenterol Hepatol 1991; 3: 321-4.
75. Siigur U, Norin KE, Allgood G, Schlagheck T, Midtvedt T. Concentrations and correlations of faecal short-chain fatty acids and faecal water content in man. Microb Ecol Health Dis 1994; 7: 287-94.
76. Hoverstad T, Bjorneklett A, Fausa O, Midtvedt T. Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol 1985; 20: 492-9.
77. Hoverstad T, Carlstedt-Duke B, Lingaas E, et al. Influence of ampicillin, clindamycin, and metronidazole on faecal excretion of short-chain fatty acids in healthy subjects. Scand J Gastroenterol 1986; 21: 621-6.
78. Hoverstad T, Midtvedt T. Short-chain fatty acids in germfree mice and rats. J Nutr 1986; 116: 1772-6.
79. Nord CE, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 1984; 76: 99-106.
80. Fleming SE, Yeo S. Production and absorption of short-chain fatty acids. In: Kritchevsky D, Bonfield C, Anderson JW, eds. Dietary Fibre: Chemistry, Physiology, and Health Effects. New York: Plenum Press, 1990: 301-15.
81. Norin KE, Carlstedt-Duke B, Hoverstad T, et al. Faecal tryptic activity in humans: influence of antibodies on microbial intestinal degradation. Microb Ecol Health Dis 1988; 1: 65-8.
82. Leijonmarck C-E, Bergstrand LO, Carlstedt-Duke B, et al. Total parenteral nutrition and the function of the intestinal microflora in Crohn's disease. Scand J Gastroenterol 1988; 23: 59-64.
83. Sleisenger MH, Fordtran JS (eds). Gastrointestinal Disease. Pathophysiology/Diagnosis/Management Vol 1, 5th edn. Philadelphia: W.B. Saunders Co., 1993: 838.
84. Finegold SM, Sutter VL, Sugihara PT, Elder HA, Lehmann SM, Phillips RL. Faecal microbial flora in Seventh Day Adventist populations and control subjects. Am J Clin Nutr 1977; 30: 1781-92.
85. Tazume S, Takeshi K, Saidi SM, et al. Ecological studies on intestinal microbial flora of Kenyan children with diarrhoea. J Trop Med Hygiene 1990; 93: 215-21.
86. Zorich NL, Biedermann D, Riccardi KA, Bishop LJ, Filloon TG. Randomized, double-blind, placebo-controlled consumer rechallenge test of Olean® salted snacks. Regul Toxicol Pharmacol 1997; 26: 200-9.
87. Zorich NL, Biedermann D, Riccardi KA, Bishop LJ, Filloon TG. Follow-up to the study: a randomized double-blind, placebo-controlled consumer rechallenge test of Olean salted snacks. Regul Toxicol Pharmacol 1998; 27: 2.
88. Cheskin LJ, Miday R, Zorich N, Filloon T. Gastrointestinal symptoms following consumption of olestra or regular triglyceride potato chips: a controlled comparison. J Am Med Assoc 1998; 279: 150-2.
89. Koonsvitsky BP, Berry DA, Jones MB, et al. Olestra affects serum concentrations of α-tocopherol: and carotenoids but not vitamin D or vitamin K status in free-living subjects. J Nutr 1997; 127: S1636-45.
90. Zorich NL, Jones MB, Kesler JM, Carter SB, Sutton MA, Bayless T. A randomized, double-blind study of the effect of olestra on disease activity in patients with quiescent inflammatory bowel disease. Am J Med 1997; 103: 389-99.
91. Curry CEJ. Handbook of Nonprescription Drugs. Washington, DC: American Pharmaceutical Association, 1986: 75-97.
92. Talley NJ, Weaver AL, Zinsmeister AR, Melton LJ III. Self-reported diarrhea: what does it mean? Am J Gastroenterol 1994; 89: 1160-4.
93. Giannella R, Zorich N, Riccardi K, Filloon T, McRorie J. Reports of diarrhea: when is stool water output clinically meaningful? A randomized, controlled clinical trial of olestra and sorbitol. Gastroenterology 1988; 114(4): G1520.
94. Cooper DA, Berry DA, Spendel VA, Kiorpes AL, Peters JC. The domestic pig as a model for evaluating olestra's nutritional effects. J Nutr 1997; 127: S1555-65.